Therefore, we queried the original data for survival time and survival status from the public databases and incorporated them into the meta‐analysis to obtain more evidence to support our research results that ITGB3BP is a risk factor for glioma patients. This evidence concerns the gene ITGB3BP and central nervous system cancer.